bioMérieux S.A. (EPA:BIM)

Market Cap	12.37B
Revenue (ttm)	4.12B
Net Income (ttm)	377.90M
Shares Out	118.07M
EPS (ttm)	3.17
PE Ratio	33.06
Forward PE	21.51
Dividend	0.90 (0.86%)
Ex-Dividend Date	Jun 9, 2025

Volume	181,034
Average Volume	109,251
Open	104.80
Previous Close	104.20
Day's Range	103.70 - 106.00
52-Week Range	96.90 - 128.30
Beta	0.65
RSI	37.01
Earnings Date	Mar 4, 2026

About bioMérieux

bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments. The company offers CHROMID RANGE, a chromogen culture media; air, surface, and water monitoring systems; BACT/ALERT VIRTUO, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system (PCR); BIOFIRE SPOTFIRE, a lowplex PCR point-of...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1963
• Employees: 14,754
• Stock Exchange: Euronext Paris
• Ticker Symbol: BIM

Financial Performance

In 2024, bioMérieux's revenue was 3.98 billion, an increase of 8.31% compared to the previous year's 3.67 billion. Earnings were 432.20 million, an increase of 20.86%.